Elizabeth S Machado Adriana O Afonso Dwight V Nissley Philippe Lemey Silvia M Cunha Ricardo H Oliveira Marcelo A Soares
10.1371/journal.pone.0004806
PLoS One
2009;4(3):e4806.
CC BY
https://pubmed.ncbi.nlm.nih.gov/19277127/
Antiretroviral Therapy, Highly Active Drug Resistance, Multiple, Viral / genetics HIV Infections / virology HIV-1 / genetics Infectious Disease Transmission, Vertical
Antiretroviral Therapy, Highly Active Drug Resistance, Multiple, Viral / genetics HIV Infections / virology HIV-1 / genetics Infectious Disease Transmission, Vertical Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Adult Didanosine / administration & dosage Didanosine / pharmacology Didanosine / therapeutic use Female HIV Infections / congenital HIV Infections / drug therapy HIV Infections / transmission HIV-1 / drug effects HIV-1 / isolation & purification Humans Infant, Newborn Lamivudine / administration & dosage Lamivudine / pharmacology Lamivudine / therapeutic use Mutation, Missense Nelfinavir / administration & dosage Nelfinavir / pharmacology Nelfinavir / therapeutic use Phylogeny Point Mutation Pregnancy Pregnancy Complications, Infectious / virology Selection, Genetic Zidovudine / administration & dosage Zidovudine / pharmacology Zidovudine / therapeutic use Lamivudine Zidovudine Nelfinavir Didanosine
PMC2652103
19277127
Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child
2009